NCM
SNTI icon

Nantahala Capital Management’s Senti Biosciences Holdings SNTI Stock Holding History

Nantahala Capital Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$977K Hold
888,000
– – 0.03% 145
2026
Q1 		$721K Hold
888,000
– – 0.03% 145
2025
Q4 		$924K Hold
888,000
– – 0.03% 137
2025
Q3 		$1.25M Hold
888,000
– – 0.04% 139
2025
Q2 		$1.87M Hold
888,000
– – 0.07% 126
2025
Q1 		$2.98M Buy
+888,000
New +$3.46M 0.12% 98

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
MVM
Menlo Ventures Management Menlo Park, California $357M AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Nantahala Capital Management's SNTI Position: Q2 2026 in Review

Nantahala Capital Management held its Senti Biosciences Holdings (SNTI) position steady in Q2 2026 at 888,000 shares worth $977K. The position accounts for 0.03% of the portfolio, ranked #145.

Nantahala Capital Management first reported a position in SNTI in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.98M in Q1 2025. 19 funds tracked by Wall St. Rank hold SNTI as of Q2 2026.

  • Nantahala Capital Management held 888,000 shares of Senti Biosciences Holdings worth $977K as of Q2 2026.
  • Nantahala Capital Management left its Senti Biosciences Holdings share count unchanged in Q2 2026.
  • Senti Biosciences Holdings made up 0.03% of Nantahala Capital Management's portfolio in Q2 2026, its #145 holding.
  • Nantahala Capital Management first reported a position in Senti Biosciences Holdings in Q1 2025 and has held it in 6 quarters since.
  • Nantahala Capital Management's Senti Biosciences Holdings position peaked at $2.98M in Q1 2025.
  • 19 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.